Medfinder
Back to blog

Updated: January 15, 2026

Why Is Combogesic So Hard to Find? [Explained for 2026]

Author

Peter Daggett

Peter Daggett

Empty pharmacy shelf with scattered medication bottles

Combogesic is a newer prescription pain reliever combining acetaminophen and ibuprofen. Here's why it can be difficult to find at pharmacies and what you can do about it.

If your doctor just prescribed Combogesic and you can't find it at your pharmacy, you're not alone. Combogesic is one of the newer combination pain medications on the U.S. market, and its availability at retail pharmacies can be inconsistent. This isn't necessarily because of a nationwide drug shortage — it's more complicated than that. Let's break it down.

What Is Combogesic?

Combogesic is a prescription-only combination analgesic containing two active ingredients: acetaminophen 325 mg and ibuprofen 97.5 mg per tablet. Adults take 3 tablets every 6 hours as needed for pain, for a maximum of 12 tablets per day. It received FDA approval in 2023 and is manufactured by Hikma Pharmaceuticals for AFT Pharmaceuticals.

There is also an intravenous version — Combogesic IV — which contains 1,000 mg of acetaminophen and 300 mg of ibuprofen in a 100 mL IV bag. This version is used exclusively in hospitals and administered by healthcare professionals. The IV form received its own FDA approval on October 17, 2023, and was launched commercially in February 2024.

Is Combogesic in a Shortage in 2026?

As of early 2026, Combogesic is not listed on the FDA or ASHP (American Society of Health-System Pharmacists) drug shortage databases. This means there is no declared, nationwide supply disruption. However, that doesn't mean every pharmacy carries it on their shelves — and for many patients, that distinction doesn't make a practical difference when they're standing at the counter in pain.

So Why Can't I Find Combogesic at My Pharmacy?

Several factors combine to make Combogesic harder to find at retail pharmacies than older, more established medications:

1. It's a Brand-Only Drug With No Generic

As of 2026, there is no FDA-approved generic version of Combogesic available in the United States. The drug's patents are protected through approximately 2035, and its new-product market exclusivity runs through October 17, 2026. Brand-only medications, particularly newer ones, are often stocked in smaller quantities at pharmacies because demand is harder to predict and the profit margin per unit is different from high-volume generics.

2. It Was Recently Launched — Distribution Is Still Ramping Up

Combogesic only received FDA approval in 2023. For newer medications, it often takes 12 to 24 months for distribution to reach every pharmacy chain and independent pharmacy nationwide. Many pharmacies simply haven't yet added Combogesic to their formulary or regular ordering cycle. This is a distribution gap, not a manufacturing shortage.

3. Prescriber Awareness Is Growing, But Uneven

As more physicians, dentists, and surgeons become aware of Combogesic's clinical evidence — particularly data showing it provides more than double the pain relief of acetaminophen IV or ibuprofen IV alone — prescribing is growing. When demand for a drug increases faster than the supply chain has time to respond, temporary stock-outs at individual pharmacies are common.

4. Broader Sterile Injectable Market Pressures (IV Form)

If you or a loved one received (or needs) Combogesic IV in a hospital setting, availability can be affected by the broader sterile injectable drug supply, which has faced persistent challenges in recent years. The ASHP reported that as of mid-2025, there were still over 200 medications in active shortage — many of them sterile injectables. While Combogesic IV itself is not on the shortage list, hospital pharmacies often manage tight inventory for all injectables.

What Can You Do If You Can't Find Combogesic?

Here are four practical steps:

Use medfinder: medfinder calls pharmacies near you to check which ones can fill your Combogesic prescription. Instead of spending hours calling pharmacies yourself, medfinder does the legwork.

Call larger chain pharmacies first: CVS, Walgreens, Walmart, and Costco pharmacies tend to have more purchasing power and may stock newer brand medications before independent pharmacies.

Ask your pharmacist to order it: If your preferred pharmacy doesn't stock Combogesic, ask if they can order it. Many pharmacies can receive special orders within 1-2 business days.

Ask your doctor about alternatives: If Combogesic is consistently unavailable, your doctor may be able to prescribe a comparable alternative. See our guide on alternatives to Combogesic.

How medfinder Can Help

Rather than calling every pharmacy in your area yourself, medfinder does it for you. You tell us your medication, dosage, and zip code, and we contact pharmacies to find which ones currently have Combogesic in stock. Results are texted to you — no hold music required. Learn more in our post: How to find Combogesic in stock near you.

The Bottom Line

Combogesic is not in an official shortage, but it is a newer brand-only medication with uneven pharmacy distribution across the United States. As prescribing grows and pharmacies expand their ordering, availability should improve. In the meantime, using a service like medfinder to locate it — rather than making dozens of phone calls yourself — is the most efficient approach.

Frequently Asked Questions

As of 2026, Combogesic is not listed on the FDA or ASHP drug shortage databases. However, its limited distribution as a newer brand-only medication means some pharmacies may not stock it. This is a supply availability gap, not an official shortage declaration.

Combogesic received FDA approval in 2023 and is still building nationwide distribution. Many pharmacies have not yet added it to their regular inventory. Calling ahead or using a service like medfinder to locate a pharmacy that stocks it is the fastest solution.

No. As of 2026, there is no FDA-approved generic version of Combogesic in the United States. Patents protecting the formulation extend through approximately 2035, and the drug's new-product market exclusivity ran through October 2026.

You should consult your doctor or pharmacist before substituting separate OTC products for prescription Combogesic. The Combogesic formulation uses specific ratios (325 mg acetaminophen / 97.5 mg ibuprofen per tablet) that differ from standard OTC doses, and the combination has been studied as a unit for safety and efficacy.

Combogesic is manufactured by Hikma Pharmaceuticals USA Inc., under license from AFT Pharmaceuticals Limited. Outside the United States, the same formulation is marketed as Maxigesic IV (for the IV form) and is approved in over 40 countries.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Combogesic also looked for:

31,889 have already found their meds with Medfinder.

Start your search today.

31K+
5-star ratingTrusted by 31,889 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?